Form 4: Medifast Director Scott Schlackman Increases Stake

Director Scott Schlackman purchased 5,000 shares of Medifast Inc. common stock across two transactions in May 2026.

Summary

• Director Scott Schlackman acquired a total of 5,000 shares of Medifast Inc. (MED) common stock.
• The purchases occurred in two separate transactions: 2,500 shares at $12.65 on May 8, 2026, and 2,500 shares at $12.53 on May 11, 2026.
• Following these transactions, the director's total beneficial ownership increased to 30,548.707 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level open market purchases typically reflect internal confidence in the company's long-term prospects.

Positives

• Director demonstrates confidence in the company's future by increasing his equity position through open market purchases.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable.

Industry Context

StockSavvy.ai notes that insider buying, particularly by directors, is often viewed by the market as a signal of management's belief that the stock is undervalued or that positive developments are expected.

Comparison to Industry Standards

• Insider buying is generally considered a positive signal compared to neutral or divestment activity in the consumer health and wellness sector.

Stakeholder Impact

• Shareholders may interpret this as a vote of confidence from leadership.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Medifast, MED, Insider Trading, Director Purchase, Equity Ownership